Nutraceutical phycocyanin nanoformulation for efficient drug delivery of paclitaxel in human glioblastoma U87MG cell line
Source abstract
Abstract
To enhance the therapeutic efficacy of chemotherapy on glioblastoma U87MG cell line, paclitaxel-loaded phycocyanin nanoparticles (PTX-PcNPs) were prepared by modified desolvation process. PTX-PcNPs were characterised in terms of size, zeta potential, drug loading efficiency and drug release. Confocal laser scanning microscopy showed PTX-PcNPs could be internalised by U87MG cells. The anti-cancer activity was investigated in vitro by 3-(4,5-dimethylthizol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay with and without photodynamic therapy. It was observed that formulation could significantly inhibit growth of U87MG cells as compared to PTX alone and also induced apoptosis, which was evidenced by presence of apoptotic bodies and nuclear fragmentation in treated cells. The present study suggests that PTX-PcNPs can act as a promising drug delivery system for cancer treatment.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photosynthetic Processes and Mechanisms · Algal biology and biofuel production · Biocrusts and Microbial Ecology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Agrawal SK, Agrawal M, Sharma PR, Gupta BD, Arora S, Saxena AK (2011) Induction of apoptosis in human promyelocytic leukemia HL60 cells by an extract from Erythrina suberosa stem bark. Nutr Cancer 63(5):802–81310.1080/01635581.2011.573900 ↗
2. Bansal A, Kapil R, Chabra N, Dhawan S (2011) Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting. Acta Pharma 61:141–15610.2478/v10007-011-0012-8 ↗
3. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA (2008) Emerging nanopharmaceuticals. Nanomedicine: NBM 4:273–28210.1016/j.nano.2008.06.002 ↗
4. Bing L, Xianming C, Meihua G, Wuxiu L (2010) Apoptotic mechanism of MCF-7 breast cells in vivo and in vitro induced by photodynamic therapy with C-phycocyanin. Acta Biochim Biophys Sinica 42(1):80–8910.1093/abbs/gmp104 ↗
5. Cho YW, Lee J, Lee SC, Huh KM, Park K (2004) Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release 97:249–25710.1016/j.jconrel.2004.03.013 ↗
6. Desai N, Trieu V, Damascelli B, Soon-Shiong P (2009) SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients. Translational Oncol 2(2):59–6410.1593/tlo.09109 ↗
7. Devi KV, Bhosle UV (2009) Formulation and optimization of polymeric nano drug delivery system of acyclovir using 32 full factorial design. Int J Pharm Tech Res 1(3):644–653
8. Eidet JR, Pasovic L, Maria R, Jackson CJ, Utheim TP (2014) Objective assessment of changes in nuclear morphology and cell distribution following induction of apoptosis. Diagn Pathol 9:9210.1186/1746-1596-9-92 ↗
9. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathology 35(4):495–51610.1080/01926230701320337 ↗
10. Fonseca C, Simões S, Gaspar R (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83(2):273–28610.1016/S0168-3659(02)00212-2 ↗
11. Gantar M, Dhandayuthapani S, Rathinavelu A (2012) Phycocyanin induces apoptosis and enhances the effect of topotecan on prostate cell line LNCaP. J Med Food 15(12):1091–109510.1089/jmf.2012.0123 ↗
12. Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. E J Cancer 37:1590–159810.1016/S0959-8049(01)00171-X ↗
13. Griffith SM, Singh N, Jenkins GJS, Williams PM, Orbaek AW, Barron AR, Wright CJ, Doak SH (2011) Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem 83:3778–378510.1021/ac200103x ↗
14. Kamble SP, Gaikar RB, Padalia RB, Shinde KD (2013) Extraction and purification of C-phycocyanin from dry Spirulina powder and evaluating its antioxidant, anticoagulation and prevention of DNA damage activity. J Appl Pharma Sci 3(08):149–153
15. Kuddus M, Singh P, Thomas G, Al-Hazimi A (2013) Recent developments in production and biotechnological applications of C-phycocyanin. Biomed Res Int 2013:1–910.1155/2013/742859 ↗
16. Langer K, Balthasar S, Vogel V, Dinauer N, Briesen HV, Schubert D (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharma 257:169–18010.1016/S0378-5173(03)00134-0 ↗
17. Liao X, Zhang X (2012) Preparation, characterization and cytotoxicity of carbon nanotube–chitosan–phycocyanin complex. Nanotechnology 23:1310.1088/0957-4484/23/3/035101 ↗
18. Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y (2014) Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int 2014:1–1210.1155/2014/180549 ↗
19. Martinez SE, Chen Y, Ho EA, Martinez SA, Davies NM (2015) Pharmacological effects of a C-phycocyanin-based multicomponent nutraceutical in an in-vitro canine chondrocyte model of osteoarthritis. Can J Vet Res 79(3):241–249
20. Miele E, Spinelli GP, Miele E, Tomao F, Tomao S (2009) Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine 4:99–105
21. Morcos NC, Berns M, Henry WL (1988) Phycocyanin: laser activation, cytotoxic effects, and uptake in human atherosclerotic plaque. Lasers Surg Med 8(1):10–1710.1002/lsm.1900080105 ↗
22. Ravi M, Tentu S, Baskar G, Prasad SR, Raghavan S, Jayaprakash P, Jeyakanthan J, Rayala SK, Venkatraman G (2015) Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. BMC Cancer 15:76810.1186/s12885-015-1784-x ↗
23. Rello S, Stockert JC, Moreno V, Gamez A, Pacheco M, Juarranz A, Canete M, Villanueva A (2005) Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10:201–20810.1007/s10495-005-6075-6 ↗
24. Romay CH, Gonzaléz R, Ledón N, Remirez D, Rimbau V (2003) C-Phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Peptide Sci 4(3):20710.2174/1389203033487216 ↗
25. Saraswathy M, Knight GT, Pilla S, Ashton RS, Gong S (2015) Multifunctional drug Nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy. Colloids Surf B Biointerfaces 126:590–59710.1016/j.colsurfb.2014.12.042 ↗
26. Sharma M, Agrawal SK, Sharma PR, Chadha BS, Khosla MK, Saxena AK (2010) Cytotoxic and apoptotic activity of essential oil from Ocimum viride towards COLO 205 cells. Food Chem Toxicol 48:336–34410.1016/j.fct.2009.10.021 ↗
27. Singh R, Lillard JR Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86(3):215–22310.1016/j.yexmp.2008.12.004 ↗
28. Teng Z, Luo Y, Wang Q (2012) Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation. J Agric Food Chem 60:2712–272010.1021/jf205238x ↗
29. Vishnu P, Roy V (2011) Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer. Breast Cancer: Basic and Clinical Res 5:53–65
30. West JL (2003) Drug delivery: pulsed polymers. Nat Mat 2:709–71010.1038/nmat1005 ↗
31. Zhang L, Jinyan F, Zhixiang X, Ping W, Zhang X (2011) Synthesis and characterization of a well-defined amphiphilic block copolymer and its paclitaxel prodrug from methoxy poly (ethylene glycol) and oligomer of glycolic acid. J Appl Polym Sci 122(2):758–76610.1002/app.33871 ↗
32. Zhen X, Wang X, Xie C, Wu W, Jiang X (2013) Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials 34(4):1372–138210.1016/j.biomaterials.2012.10.061 ↗